Literature DB >> 3607277

Eosinophils do respond to fMLP.

M Yazdanbakhsh, C M Eckmann, L Koenderman, A J Verhoeven, D Roos.   

Abstract

Eosinophils were isolated from normal human blood by separation over Percoll gradients, which resulted in eosinophil suspensions of a purity higher than 95% and recoveries of about 65%. Normal human eosinophils were found to respond to formyl-methionyl-leucyl-phenylalanine (fMLP) at concentrations greater than 10(-7) mol/L with an increase in the concentration of intracellular free calcium, oxygen consumption, nitroblue tetrazolium reduction, and chemiluminescence. The maximal response of eosinophils to fMLP was lower than that of neutrophils isolated from the same blood samples and required at least ten times as much fMLP as was needed for neutrophils. Low fMLP concentrations (approximately 10(-8) mol/L), which in themselves did not stimulate O2 consumption by either eosinophils or neutrophils, primed these cells to respond to a suboptimal concentration of another stimulus. Purification of eosinophils after treatment of whole blood with fMLP showed that these eosinophils had lost their ability to respond to fMLP. We conclude that normal eosinophils do respond to fMLP and that therefore fMLP should not be used to isolate eosinophils.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3607277

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  Isolation of human eosinophils.

Authors:  K G Lim; P F Weller
Journal:  Curr Protoc Immunol       Date:  2001-05

2.  Intracellular reactions in single human granulocytes upon phorbol myristate acetate activation using confocal Raman microspectroscopy.

Authors:  N M Sijtsema; A G Tibbe; I G Segers-Nolten; A J Verhoeven; R S Weening; J Greve; C Otto
Journal:  Biophys J       Date:  2000-05       Impact factor: 4.033

3.  Directional cellular movement of cell populations: its description by chemotactic assays.

Authors:  G K Terpstra; L A Houben
Journal:  Agents Actions       Date:  1989-01

4.  Differential regulation of the activation of human eosinophils, macrophages, and neutrophils: effect of the allergic mediator release inhibitor CI-949.

Authors:  C D Wright; L J Devall; D O Aker; D O Thueson; M C Conroy
Journal:  Agents Actions       Date:  1990-08

Review 5.  The role of eosinophils in non-parasitic infections.

Authors:  Stefanie N Linch; Jeffrey A Gold
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2011-06       Impact factor: 2.895

6.  Pathogenic natural anti-cardiolipin antibodies: the experience from monoclonal gammopathy.

Authors:  J Cohen; R Bakimer; M Blank; G Valesini; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

7.  Differential regulation of human eosinophil, macrophage, and neutrophil functions by the allergic mediator release inhibitor CI-959.

Authors:  C D Wright; L J Devall; K A Aker; D O Thueson; M C Conroy
Journal:  Agents Actions       Date:  1992-05

8.  Resonance Raman microspectroscopy of myeloperoxidase and cytochrome b558 in human neutrophilic granulocytes.

Authors:  N M Sijtsema; C Otto; G M Segers-Nolten; A J Verhoeven; J Greve
Journal:  Biophys J       Date:  1998-06       Impact factor: 4.033

9.  FMLP is a potent activator of guinea-pig eosinophils but its activity is dependent on the prior overnight in vitro culture of the cells (facilitation).

Authors:  M K Bach; J R Brashler
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

10.  The effect of platelet-activating factor on IgE binding to, and IgE-dependent biological properties of, human eosinophils.

Authors:  R Moqbel; G M Walsh; T Nagakura; A J MacDonald; A J Wardlaw; Y Iikura; A B Kay
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.